We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OPQ Outlines New Inspection, Reporting Paradigm, Organizational Structure
OPQ Outlines New Inspection, Reporting Paradigm, Organizational Structure
The FDA’s Office of Pharmaceutical Quality is developing a new inspection protocol that will focus on expert investigator-developed questions and assessment practices.